Both EuCanImage (AI passport, clinical effectiveness of imaging AI) and ENVISION (smart decision support for ICU patients) focus on deploying AI tools in clinical settings.
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS
Lithuania's largest university hospital providing clinical data, patient cohorts, and validation sites for AI-driven health research across cancer, critical care, and infectious disease.
Their core work
Kaunas Clinics is the largest university hospital in Lithuania, operating as the clinical arm of the Lithuanian University of Health Sciences. In H2020, they contribute clinical data, patient cohorts, and medical expertise to European research consortia focused on AI-driven healthcare, infectious disease modelling, and cancer imaging. Their role centers on providing real-world clinical environments — intensive care units, oncology departments — where digital health tools and predictive models can be validated against actual patient outcomes.
What they specialise in
ENVISION specifically targets real-time surveillance and predictive modelling in intensive care units during COVID-19.
EuCanImage involves large-scale cancer imaging, collaborative data annotation, and clinical requirements for an EU-wide cancer image platform.
PrIMAVeRa (2021-2026) studies how monoclonal antibodies and vaccines impact antibiotic resistance patterns using mathematical modelling.
EuCanImage addresses ethical and legal interoperability for health data, while ENVISION involves digitalisation and real-time monitoring infrastructure.
How they've shifted over time
Kaunas Clinics entered H2020 in 2020 with a focus on digital health infrastructure — AI governance frameworks, cancer imaging platforms, and data interoperability standards. By 2021, their work shifted toward infectious disease challenges: COVID-19 critical care analytics and antimicrobial resistance prediction. This trajectory shows a hospital moving from structured digital health projects toward urgent, real-world clinical problems where data-driven tools meet acute patient needs.
Moving toward predictive modelling for infectious diseases and antimicrobial resistance — a growth area where clinical data from a major university hospital is highly valuable.
How they like to work
Kaunas Clinics operates exclusively as a participant, never as a coordinator — consistent with a large clinical institution that provides patient data, clinical validation sites, and medical expertise rather than leading project management. With 63 unique partners across 19 countries from just 3 projects, they join large, well-funded consortia. This makes them an accessible partner: they are experienced in multi-site clinical studies and accustomed to working within complex international teams.
Despite only 3 projects, they have built connections with 63 partners across 19 European countries, reflecting participation in large-scale health consortia with broad geographic coverage.
What sets them apart
As Lithuania's largest university hospital, Kaunas Clinics offers something few Baltic research institutions can: direct access to diverse clinical populations and hospital infrastructure for validating digital health tools in real care settings. Their combination of cancer imaging data, ICU patient monitoring, and infectious disease cohorts makes them a versatile clinical partner. For consortium builders, they represent a credible clinical site in an EU-13 country — useful for geographic diversity requirements in Horizon Europe proposals.
Highlights from their portfolio
- EuCanImageTheir largest funded project (EUR 181K), contributing clinical requirements and data annotation to a pan-European AI-powered cancer imaging platform.
- PrIMAVeRaA forward-looking project (running to 2026) modelling how vaccines and monoclonal antibodies affect antimicrobial resistance — a major global health priority.
- ENVISIONA rapid-response COVID-19 project deploying AI-based real-time surveillance tools in intensive care units, demonstrating the hospital's ability to mobilize for urgent health crises.